Skip to content

Released Mar 26, 2020, after the close

10-K filed Mar 26, 2020, 86 days after period end · 0001493152-20-004807

Q4 2019 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$3.14Mderived−23.3% vs Q4 2018+13.6% vs Q3 2019
Net Income-$467.00KderivedN/M vs Q4 2018N/M vs Q3 2019
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$1,000,000−25.5%
Operating Incomederived-$466,000N/M
Operating Cash Flowderived-$428,000N/M
Free Cash Flowderived-$471,000N/M
Margins · derived
Gross margin31.8%−0.9 pt vs Q4 2018
Operating margin-14.8%−4.9 pt vs Q4 2018
Net margin-14.9%−3.5 pt vs Q4 2018

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2019derived from reported figuresQ4 2018derived from reported figuresQ4 2017derived from reported figuresQ4 2016derived from reported figures
Revenue$3.14M$4.09M$4.15M$767.00K
Net Income-$467.00K-$467.00K-$217.00K-$572.00K

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR